This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Harbour Biomed (Suzhou) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Lei Shi, Antibody Innovation in Suzhou
Introduction
Lei Shi is an inventor based in Suzhou, China, whose patent work focuses on antibody-based therapeutics. Her listed inventions include approaches involving BCMA-targeting and CD3-targeting antibodies.
Latest Patents
Shi’s latest listed patents are “Antibody Targeting BCMA, Bispecific Antibody, and Use Thereof” and “CD3-Targeting Antibody, Bispecific Antibody and Use Thereof.” Together, these inventions reflect research into bispecific antibodies and their potential uses. Shi is associated with 2 patents.
Career Highlights
Shi is associated with Harbour Biomed (Suzhou) Co., Ltd. Her patent portfolio highlights antibody engineering as a central area of her inventive work.
Collaborations
Her listed coworkers include Yun He and Xuekun Zhang, reflecting a collaborative research environment at Harbour Biomed.
Conclusion
Lei Shi’s patent record connects her work in Suzhou with antibody innovation, including bispecific antibody inventions targeting BCMA and CD3.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile